Digital Health and SaMD: Core Regulatory Concepts for RA Professionals Digital Health and SaMD: Core Regulatory Concepts for RA Professionals Context As the digital health landscape evolves, regulatory affairs professionals must navigate a complex framework of regulations and guidelines that govern software as a medical device (SaMD) and artificial intelligence (AI)-driven products. With the integration of technology into healthcare, it is crucial to understand the expectations set forth by agencies like the FDA, EMA, and MHRA. This article aims to provide a comprehensive manual for regulatory affairs professionals focusing on the core regulatory concepts associated with SaMD and digital health…

AI-Driven Medical Products: Emerging Expectations from FDA, EMA and MHRA AI-Driven Medical Products: Emerging Expectations from FDA, EMA and MHRA Context The landscape of regulatory affairs is rapidly evolving, particularly with the emergence of artificial intelligence (AI) and digital health technologies. Traditional regulatory frameworks are challenged by the need to maintain safety, effectiveness, and quality while also encouraging innovation. This article aims to provide a comprehensive understanding of the current regulatory expectations from the FDA, EMA, and MHRA regarding AI-driven medical products, with a focus on service pharmacovigilance, real-world evidence, and adaptive pathways. Legal/Regulatory Basis The regulation of AI-driven medical…

Classifying Digital Health Products: Device, SaMD, Wellness or Clinical Decision Support? Classifying Digital Health Products: Device, SaMD, Wellness or Clinical Decision Support? As the realm of healthcare continues to evolve with digital innovations, the classification of digital health products becomes increasingly crucial within regulatory frameworks. This regulatory explainer manual provides an in-depth guide on how various digital health products, including Software as a Medical Device (SaMD), wellness apps, and Clinical Decision Support (CDS) systems, are classified across major jurisdictions such as the US, UK, and EU. Context The digital health sector encompasses a wide range of products aimed at enhancing…

Evidence Requirements for SaMD and AI Tools Used in Clinical Care Evidence Requirements for SaMD and AI Tools Used in Clinical Care The landscape of healthcare is rapidly evolving with the introduction of Software as a Medical Device (SaMD) and Artificial Intelligence (AI) tools designed to enhance clinical care. As these technologies gain traction, regulatory compliance firms are left to navigate the complexities of ensuring such innovations meet necessary regulatory standards. This article serves as a comprehensive regulatory explainer manual, delving into the relevant regulations, guidelines, and agency expectations surrounding SaMD and AI applications in clinical practice. Context SaMD refers…

Algorithm Change Protocols, Learning Systems and Regulatory Controls Algorithm Change Protocols, Learning Systems and Regulatory Controls Context The rapid expansion of digital health technologies and artificial intelligence (AI) has significantly changed the landscape of regulatory affairs. Specifically, the development of Software as a Medical Device (SaMD) and AI-driven products presents unique challenges and opportunities. Within this evolving context, understanding the regulatory expectations surrounding global pharmacovigilance becomes essential for Regulatory Affairs (RA) teams, particularly as they prepare for the implications of new algorithms and learning systems that could impact patient safety and product efficacy. Legal and Regulatory Basis Regulations governing the…

Cybersecurity, Data Privacy and Data Integrity in Digital Health Regulation Cybersecurity, Data Privacy and Data Integrity in Digital Health Regulation The rise of digital health technologies, particularly Software as a Medical Device (SaMD) and artificial intelligence (AI)-driven products, has necessitated an evolution in regulatory frameworks. This article aims to provide a comprehensive regulatory explainer manual focusing on the expectations surrounding cybersecurity, data privacy, and data integrity in the context of pharmaceutical laws, emerging regulatory policy trends, and AI digital health within global convergence in regulation. Context As the pharmaceutical and biotechnology industries increasingly embrace digital health innovations, regulatory affairs professionals…

Case Studies: AI and SaMD Products that Navigated Regulatory Approval Case Studies: AI and SaMD Products that Navigated Regulatory Approval Context Digital health technologies, particularly Software as a Medical Device (SaMD) and Artificial Intelligence (AI)-driven products, have rapidly evolved within the healthcare landscape. Regulatory Affairs professionals are tasked with navigating the complexities of the evolving regulatory environment surrounding these innovations. The integration of AI into healthcare presents unique challenges and opportunities for regulatory compliance, particularly concerning pharmacovigilance solutions and the use of real-world evidence in regulatory submissions. This article will explore the regulatory landscape for these products, delving into key…

Risk Management and Human Factors for Software-Enabled Medical Products Risk Management and Human Factors for Software-Enabled Medical Products Context The rapid evolution of software-enabled medical products (SEMP), including software as a medical device (SaMD), presents both opportunities and challenges for regulatory affairs professionals. As the adoption of digital health technologies accelerates, understanding the regulatory expectations related to risk management and human factors is essential. Both regulatory bodies and industry stakeholders are pushing for clear frameworks that ensure patient safety while fostering innovation. In this context, regulatory affairs and compliance play a pivotal role in bridging the gap between technology and…

Real-World Performance Monitoring and Post-Market Requirements for SaMD Real-World Performance Monitoring and Post-Market Requirements for SaMD As the landscape of healthcare technology evolves, Software as a Medical Device (SaMD) has emerged as a critical area within Regulatory Affairs. Given the rapid advancements in artificial intelligence (AI), digital health, and the need for effective regulatory oversight, understanding compliance requirements for SaMD is essential for regulatory professionals. This article explores the regulatory framework governing SaMD, focusing on compliance regulatory affairs, real-world evidence and adaptive pathways, and emerging trends affecting global regulation. Context The rise of digital health products, particularly SaMD, necessitates a…

Global Guidance Landscape on AI in Medical Devices and Drug Development Global Guidance Landscape on AI in Medical Devices and Drug Development Context The rapid evolution of artificial intelligence (AI) in the fields of medical devices and drug development has significantly changed the landscape of regulatory affairs compliance. Healthcare organizations are increasingly leveraging AI technologies, including software as a medical device (SaMD), which has prompted regulatory agencies worldwide to reevaluate existing frameworks and develop new guidance tailored to the unique challenges and opportunities presented by these advancements. In this article, we explore the regulatory expectations surrounding AI-driven products, emphasizing compliance…